企業プロフィール

Assertio 株価・ニュース・カタリスト

ティッカー:: ASRT
取引所:: NASDAQ
セクター:: Biopharma
所在地:: United States

株価パフォーマンス

23.50 USD (+0.13%)

終値

最終更新: 2026年6月15日

152M USD

時価総額

株価変動の要因

Current closing-price context is not available for ASRT.

企業概要

事業概要

Assertio is a specialty pharmaceutical company with a portfolio of neurology, pain, and related products. The story is largely about managing a concentrated commercial base while expanding selectively.

所在地とセクター分類

Headquartered in the United States and listed on NASDAQ, Assertio sits in specialty biopharma.

ビジネスモデルの特徴

The business depends on product revenue, portfolio management, and the ability to stabilize and grow its commercial assets.

バイオ業界での位置付け

Assertio is a specialty-pharma turnaround name with a story shaped by product mix and execution.

今後のカタリスト

Assertio’s catalysts are its branded pain and neurology portfolio, including Sympazan and Indocin, plus any capital-allocation or portfolio-optimization update. The market will care more about cash generation and simplification than about big pipeline headlines.